According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $4.37 B. In 2022 the company made an earning of $4.85 B a decrease over its 2021 earnings that were of $9.32 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $4.37 B | -9.93% |
2022 | $4.85 B | -47.9% |
2021 | $9.32 B | 144.75% |
2020 | $3.81 B | 56.86% |
2019 | $2.42 B | -4.87% |
2018 | $2.55 B | 22.85% |
2017 | $2.07 B | 56.3% |
2016 | $1.32 B | 8.55% |
2015 | $1.22 B | 57.92% |
2014 | $0.77 B | 8.75% |
2013 | $0.71 B | 72.13% |
2012 | $0.41 B | -285.93% |
2011 | -$0.23 B | 121.3% |
2010 | -$0.11 B | 30.6% |
2009 | -$77.13 M | -9.88% |
2008 | -$85.59 M | -25.23% |
2007 | -$0.12 B | 6.32% |
2006 | -$0.11 B | -186.52% |
2005 | $0.12 B | 2103.7% |
2004 | $5.64 M | -105.75% |
2003 | -$98.16 M | -19.52% |
2002 | -$0.13 B | 47.09% |
2001 | -$82.92 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $24.43 B | 458.38% | ๐บ๐ธ USA |
![]() Novartis NVS | $8.80 B | 101.12% | ๐จ๐ญ Switzerland |
![]() Amgen AMGN | $8.75 B | 99.96% | ๐บ๐ธ USA |
![]() Sanofi SNY | $10.77 B | 146.25% | ๐ซ๐ท France |
![]() Biogen BIIB | $1.60 B | -63.23% | ๐บ๐ธ USA |
![]() Alnylam Pharmaceuticals
ALNY | -$0.39 B | -108.75% | ๐บ๐ธ USA |